The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica
Abstract
BACKGROUND: Autoantibody specific for the aquaporin-4 astrocytic water channel is restricted to serum and CSF of patients with neuromyelitis optica (NMO) and related CNS inflammatory demyelinating disorders (relapsing optic neuritis and longitudinally extensive transverse myelitis). NMO-typical lesions are distinct from MS-typical lesions. Aquaporin-4 is lost selectively at vasculocentric sites of edema/inflammation coinciding with focal deposits of immunoglobulins (Ig) G, M, and terminal complement products, with and without myelin loss. Evidence for antigen-specific autoantibody pathogenicity is lacking. METHODS: We used confocal microscopy and flow cytometry to evaluate the selectivity and immunopathological consequences of Ig binding to surface epitopes of living target cells expressing aquaporin-4 fused at its cytoplasmic N-terminus with GFP. We tested serum, IgG-enriched and IgG-depleted serum fractions, and CSF from patients with NMO, neurologic control patients, and healthy subjects. We also analyzed aquaporin-4 immunoreactivity in myelinated adult mouse optic nerves and spinal cord, and plasma cell Ig isotypes in archived brain tissue from an NMO patient. RESULTS: Serum IgG from patients with NMO binds to the extracellular domain of aquaporin-4; it is predominantly IgG(1), and it initiates two potentially competing outcomes, aquaporin-4 endocytosis/degradation and complement activation. Serum and CSF lack aquaporin-4-specific IgM, and plasma cells in CNS lesions of NMO contain only IgG. Paranodal astrocytic endfeet highly express aquaporin-4. CONCLUSIONS: NMO patients' serum IgG has a selective pathologic effect on cell membranes expressing aquaporin-4. IgG targeting astrocytic processes around nodes of Ranvier could initiate demyelination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239 · cited 1×
“6,7 Detection of NMO-IgG allows distinction of NMO from relapsing–remitting MS, with which it is often confused.(1,3-5,8) NMO is recognized traditionally by a selective involvement of the spinal cord (typically longitudinally extensive lesions) and optic nerve,8 severe clinical morbidity, and destructive immunopatholo…”
BackgroundSelf-citationWalport, M. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441406 · Cited by 2,927
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288
Self-citationRaff, M. C., Miller, R. H., & Noble, M. (1983) · Nature · doi:10.1038/303390a0 · Cited by 2,030
The clinical course of neuromyelitis optica (Devic’s syndrome)
Wingerchuk, D. M., Hogancamp, W. F., O’Brien, P. C., & Weinshenker, B. G. (1999) · Neurology · doi:10.1212/wnl.53.5.1107 · Cited by 1,822
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
Lucchinetti, C. F. (2002) · Brain · doi:10.1093/brain/awf151 · Cited by 1,210
Self-citationGlutamate excitotoxicity in a model of multiple sclerosis
Pitt, D., Werner, P., & Raine, C. S. (2000) · Nature Medicine · doi:10.1038/71555 · Cited by 744
The molecular basis of water transport in the brain
Amiry-Moghaddam, M., & Ottersen, O. P. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1252 · Cited by 733
Roemer, S. F., Parisi, J. E., Lennon, V. A., Benarroch, E. E., Lassmann, H., Bruck, W., Mandler, R. N., Weinshenker, B. G., Pittock, S. J., Wingerchuk, D. M., et al. (2007) · Brain · doi:10.1093/brain/awl371 · Cited by 716
Self-citationNeuromyelitis Optica Brain Lesions Localized at Sites of High Aquaporin 4 Expression
Pittock, S. J., Weinshenker, B. G., Lucchinetti, C. F., Wingerchuk, D. M., Corboy, J. R., & Lennon, V. A. (2006) · Archives of Neurology · doi:10.1001/archneur.63.7.964 · Cited by 701
Self-citationBrain Abnormalities in Neuromyelitis Optica
Pittock, S. J., Lennon, V. A., Krecke, K., Wingerchuk, D. M., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Archives of Neurology · doi:10.1001/archneur.63.3.390 · Cited by 675
Self-citationAn open label study of the effects of rituximab in neuromyelitis optica
Cree, B. A. C., Lamb, S., Morgan, K., Chen, A., Waubant, E., & Genain, C. (2005) · Neurology · doi:10.1212/01.wnl.0000159399.81861.d5 · Cited by 646
Plasma exchange for severe attacks of CNS demyelination: Predictors of response
Keegan, M., Pineda, A. A., McClelland, R. L., Darby, C. H., Rodriguez, M., & Weinshenker, B. G. (2002) · Neurology · doi:10.1212/wnl.58.1.143 · Cited by 600
NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury
Salter, M. G., & Fern, R. (2005) · Nature · doi:10.1038/nature04301 · Cited by 553
Bhat, M. A., Rios, J. C., Lu, Y., Garcia-Fresco, G. P., Ching, W., Martin, M. S., Li, J., Einheber, S., Chesler, M., Rosenbluth, J., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00294-x · Cited by 552
Mcdonald, J. W., Althomsons, S. P., Hyrc, K. L., Choi, D. W., & Goldberg, M. P. (1998) · Nature Medicine · doi:10.1038/nm0398-291 · Cited by 544
Meri, S., Morgan, B. P., Davies, A., Daniels, R. H., Olavesen, M. G., Waldmann, H., & Lachmann, P. J. (1990) · PubMed Central · Cited by 533
Debus, E., Weber, K., & Osborn, M. (1984) · Differentiation · doi:10.1111/j.1432-0436.1984.tb01355.x · Cited by 487
ARRAYS OF PARTICLES IN FREEZE-FRACTURED ASTROCYTIC MEMBRANES
Landis, D. M. D., & Reese, T. S. (1974) · The Journal of Cell Biology · doi:10.1083/jcb.60.1.316 · Cited by 256
Expression of complement in the brain: role in health and disease
Morgan, B. P., & Gasque, P. (1996) · Immunology Today · doi:10.1016/0167-5699(96)20028-f · Cited by 230
DE PETRIS, S., & RAFF, M. C. (1973) · Nature New Biology · doi:10.1038/newbio241257a0 · Cited by 198
Aquaporin-4 deficiency down-regulates glutamate uptake and GLT-1 expression in astrocytes
Zeng, X.-N., Sun, X.-L., Gao, L., Fan, Y., Ding, J.-H., & Hu, G. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.09.008 · Cited by 183
NMO-IgG in the diagnosis of neuromyelitis optica
Jarius, S., Franciotta, D., Bergamaschi, R., Wright, H., Littleton, E., Palace, J., Hohlfeld, R., & Vincent, A. (2007) · Neurology · doi:10.1212/01.wnl.0000256822.01222.bd · Cited by 181
Establishment of a New Sensitive Assay for Anti-Human Aquaporin-4 Antibody in Neuromyelitis Optica
Takahashi, T., Fujihara, K., Nakashima, I., Misu, T., Miyazawa, I., Nakamura, M., Watanabe, S., Ishii, N., & Itoyama, Y. (2006) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.210.307 · Cited by 165
Farkas, I., Baranyi, L., Ishikawa, Y., Okada, N., Bohata, C., Budai, D., Fukuda, A., Imai, M., & Okada, H. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2001.013381 · Cited by 126
Rash, J. E., Davidson, K. G. V., Yasumura, T., & Furman, C. S. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.076 · Cited by 120
Simón, I., Vendrell, J., Gutiérrez, C., Fernández-Real, J., Vendrell, I., Gallart, L., Fontova, R., & Richart, C. (2002) · Hormone Research in Paediatrics · doi:10.1159/000064490 · Cited by 104
Cited by
Development, maintenance and disruption of the blood-brain barrier
Obermeier, B., Daneman, R., & Ransohoff, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3407 · Cited by 2,452
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
Dalmau, J., Lancaster, E., Martinez-Hernandez, E., Rosenfeld, M. R., & Balice-Gordon, R. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70253-2 · Cited by 2,435
Aquaporin 4 and neuromyelitis optica
Papadopoulos, M. C., & Verkman, A. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70133-3 · Cited by 597
Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica
Bennett, J. L., Lam, C., Kalluri, S. R., Saikali, P., Bautista, K., Dupree, C., Glogowska, M., Case, D., Antel, J. P., Owens, G. P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21802 · Cited by 590
Aquaporins: important but elusive drug targets
Verkman, A. S., Anderson, M. O., & Papadopoulos, M. C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4226 · Cited by 586
Metadata
- Authors
- Hinson, S. R., Pittock, S. J., Lucchinetti, C. F., Roemer, S. F., Fryer, J. P., Kryzer, T. J., & Lennon, V. A.
- Venue
- Neurology
- Published
- 2007-12-11
- Volume
- 69
- Issue
- 24
- Pages
- 2221-2231
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2067927161
- Cited by
- 494
- References
- 28
- FWCI
- 19.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.